Structural Insights into Adeno-Associated Virus Serotype 5 - Wikidata - wikimedia - TriplyDB

Structural Insights into Adeno-Associated Virus Serotype 5

Structural Insights into Adeno-Associated Virus Serotype 5

http://www.wikidata.org/entity/Q27679454

about

The structure of AAVrh32.33, a novel gene delivery vector Structure of neurotropic adeno-associated virus AAVrh.8.Comparative analysis of adeno-associated virus capsid stability and dynamics Do's and don'ts of cryo-electron microscopy: a primer on sample preparation and high quality data collection for macromolecular 3D reconstruction.Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy Identification and mutagenesis of the adeno-associated virus 5 sialic acid binding region.Structure of an enteric pathogen, bovine parvovirus Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering.Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors Adeno-associated virus structural biology as a tool in vector development.Engineering adeno-associated viruses for clinical gene therapy.Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.Evaluation of the expression pattern of rAAV2/1, 2/5, 2/7, 2/8, and 2/9 serotypes with different promoters in the mouse visual cortex.Recent progress and considerations for AAV gene therapies targeting the central nervous system.

P2860

Q27682946-2B65EAA4-F525-406F-A99C-ACB2A3FF68A8 Q30152836-A3A6952A-3CCF-4C2A-8BC2-2D648E4410C9 Q30557598-5EB33D7D-358D-4E50-8AF3-DEDE65EF4677 Q30887503-2116D742-91CB-42D5-B23A-2325E658E428 Q34535290-A8620834-D609-471B-937B-A72E26EC8BD6 Q34991472-A60F5047-46B3-493A-8729-D827FAAA8079 Q35076783-FCA6BCE4-95AB-4852-B503-CC5FF80FC2B7 Q35210473-5211D60A-4A09-4BE4-9727-326BE41AE559 Q35450610-677472A6-AC76-4CEE-B082-9BEDD578557C Q36406869-506C1980-D016-41A5-88B3-785FDD4A3A79 Q36736418-5B3A7DAD-8DA6-4192-B50A-D3A451DB5818 Q38187651-B11677AD-686E-46A4-BB8B-A0A43D3156D5 Q38188560-9556C822-70B0-43CF-9FCE-53447BFA6B8D Q38212776-8EBD1A64-BCD2-4511-871A-B620F100E4C9 Q39578007-D40415DF-8031-425C-8AD8-0AB14C961B59 Q41606960-AD7A80F4-5B46-401A-A793-1898A0571ED5 Q41716240-AF8D46A5-B223-458F-9F14-D95F93839149 Q54206545-65AE292A-630C-4377-9400-617F4F5D9450

P2860

Structural Insights into Adeno-Associated Virus Serotype 5

http://www.wikidata.org/entity/Q27679454

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Structural Insights into Adeno-Associated Virus Serotype 5

@ast

Structural Insights into Adeno-Associated Virus Serotype 5

@en

Structural Insights into Adeno-Associated Virus Serotype 5

@nl

type

label

Structural Insights into Adeno-Associated Virus Serotype 5

@ast

Structural Insights into Adeno-Associated Virus Serotype 5

@en

Structural Insights into Adeno-Associated Virus Serotype 5

@nl

prefLabel

Structural Insights into Adeno-Associated Virus Serotype 5

@ast

Structural Insights into Adeno-Associated Virus Serotype 5

@en

Structural Insights into Adeno-Associated Virus Serotype 5

@nl

P1433

Q27679454-49FC1485-6997-44F1-BA1D-DFFE189A3806

P1476

Q27679454-3CE2F726-C5A5-4CDC-8F51-93C981A36F7D

P2093

Q27679454-276FF4B9-8841-4DFF-A0BC-37B3450BEC55

Q27679454-2962426F-2448-4DBB-8004-717DE72F8871

Q27679454-3A1C423F-7B00-49D3-A665-22F5A6386CEC

Q27679454-65A57B56-3142-4B05-9664-5673AB3A4741

Q27679454-C4A185AF-A5AB-4FA6-B95F-5574B5D9C113

P2860

Q27679454-00A7CD14-1E9D-48BA-957F-DC75BB599997

Q27679454-01455065-5321-4FAF-8F54-5645402EE08E

Q27679454-01973181-A41B-401F-976B-DD39B32BDB9B

Q27679454-01FECF9F-E0F6-40FF-B11B-053498A7C02C

Q27679454-0237C72F-0F4A-4CCE-9657-6381D90FDF72

Q27679454-04661433-D799-44D6-9873-589C21CACF02

Q27679454-049B5928-628C-4FEC-8235-8930037AA164

Q27679454-0519E157-3FBC-47CE-BEBF-25DA6CFF21F0

Q27679454-0E534712-EA64-4CD7-95F1-154137D5E458

Q27679454-0F334C23-4F0A-4C82-B64B-03732AB829B8

P304

Q27679454-03F7E187-130A-4681-9A4E-0D8A74B3FCF7

P31

Q27679454-DF635511-40F2-4D13-9801-89C17907BDB0

P356

Q27679454-F6EC199A-1153-4C43-86D1-92D935AB6186

P433

Q27679454-9105C834-6C5E-40A3-8302-8BE4CD0B813C

P478

Q27679454-54A0885D-5F2F-44AC-9587-8DE211AFA30D

P50

Q27679454-0A886DFC-BC55-4E74-9183-3B53FB7FACDF

Q27679454-78359BDC-9582-4BA4-81AE-809267FB0B7B

Q27679454-A490B631-E467-4C4F-80E8-02EDC10E082C

Q27679454-B2BF0140-8CB2-419C-94D4-E2AB20944E1C

P577

Q27679454-9E6B1304-45FC-4122-A3FB-890C2CAD5E9F

P5875

Q27679454-E07B5F5B-2C50-4FE3-9CD8-26E780201496

P698

Q27679454-B13BFDCE-ABB8-4A2D-8FBB-7788C3C43A83

P932

Q27679454-17F79297-C296-44AF-A57C-739AE08AA1B0

P356

P1433

Journal of Virology

P1476

Structural Insights into Adeno-Associated Virus Serotype 5

@en

P2093

John A Chiorini

http://www.w3.org/2001/XMLSchema#string

Michael A DiMattia

http://www.w3.org/2001/XMLSchema#string

Nicholas Muzyczka

http://www.w3.org/2001/XMLSchema#string

Sergei Zolotukhin

http://www.w3.org/2001/XMLSchema#string

Sujata Halder

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year

P304

11187-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00867-13

http://www.w3.org/2001/XMLSchema#string

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Mavis Agbandje-McKenna

Lakshmanan Govindasamy

Brittney L Gurda

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255707443

http://www.w3.org/2001/XMLSchema#string

P698

23926356

http://www.w3.org/2001/XMLSchema#string

P932

3807309

http://www.w3.org/2001/XMLSchema#string